Coronary artery bypass grafting (CABG) has been the standard of care for the management of left main stem (LMS) disease (1) (2) (3) (4) (5) . In contemporary practice, however, percutaneous coronary intervention (PCI) has become an alternative strategy in patients who have unprotected left main stem (UPLMS) disease, particularly in those deemed at high risk for surgery (6) , even though repeat revascularization procedures are increased with LMS PCI compared with CABG (2) . Notably, higher rates of success are not confined to elective patients with chronic stable angina (CSA), and favorable outcomes have been reported in emergency cases when CABG is often contraindicated (7) (8) (9) . Yet, for patients who receive PCI to disease of the UPLMS, there is a paucity of data that measure outcomes in unselected patients on a large scale and in a consecutive series. There is, therefore, value in reporting contemporary and representative outcomes data for PCI to the UPLMS in order to inform patients, healthcare professionals, and regulators of both the benefits and inherent risks of such therapy, and also to highlight areas where novel interventions aimed at improving outcomes may be targeted (7, (10) (11) (12) (13) (14) (15) . Moreover, there is a gap in the knowledge base regarding the relative merits of PCI to an UPLMS culprit lesion in patients who present with ST-segment elevation myocardial infarction (STEMI) or non-STsegment elevation acute coronary syndrome (NSTEACS) (16) . For patients with cardiogenic shock, there are very limited data available in the published reports, with early outcomes reported in only small "hypothesis-generating" cohort studies. Similarly, although recent international guidelines recommend a radial approach to PCI over that of the femoral approach (17) , the wider implications of this have not been studied in patients who receive PCI to disease of the UPLMS.
The British Cardiovascular Intervention Society (BCIS) registry is a prospective whole-country registry of all PCIs in adults that has collected patient-level data from all centers in the United Kingdom since 2005. It provides data that cannot be collected within a randomized controlled trial, and few cohort studies have comparable population coverage, long-term follow-up, and depth of data detail in relation to clinical risk. The primary aim of this study was to perform a population-based comparative investigation into the clinical outcomes of patients who received PCI to an UPLMS stenosis, according to clinical syndrome at presentation. Our secondary aims were: 1) to quantify the impact of cardiogenic shock; and 2) to report the impact of the radial versus femoral approach on outcomes by clinical presentation.
Methods
Setting and design. This study was on the basis of data from the BCIS audit program, in which participation is mandated for all PCI operators and all hospitals in the United Kingdom (18) . Data for every PCI procedure performed were collected prospectively at each hospital. These data were then encrypted and transferred securely online to a central database, using a system developed by the Central Cardiac Audit Database, now part of the National Institute for Cardiovascular Outcomes Research (NICOR). The data for each PCI procedure comprise 113 core fields that describe the patient demographics and clinical presentation, indications for PCI, procedural details, and outcomes during the hospital stay (19) . Patients, procedures, and treatments. Although BCIS collects data from all countries in the United Kingdom, robust mortality tracking is only available for patients who live in England and Walesdthis represents approximately 89% of the U.K. population. Thus, the sampling frame comprised all patients in England and Wales. Patients were eligible for the UPLMS analyses if they had received PCI to a diseased UPLMS during a 6-year period between January 1, 2005, and December 31, 2010, and were at least 18 years of age. These patients were drawn from those who had the left main stem as the treated vessel. Patients with an UPLMS were defined as those who did not have a patent graft to any leftsided coronary artery (18) . For those with multiple admissions, we used the earliest record. We defined 3 strata, STEMI, NSTEACS, and CSA, according to the mode of clinical presentation. The consensus document of the Joint European Society of Cardiology/American College of Cardiology was used as the diagnostic standard for acute myocardial infarction (AMI) and provided the basis for categorization by the local supervising cardiologist into STEMI and NSTEACS groups, according to the clinical presentation, electrocardiogram, and troponin level where appropriate (20) . The STEMI group included patients receiving primary PCI, rescue PCI, PCI for reinfarction, and facilitated PCI for STEMI. Cardiogenic shock was defined as a systolic blood pressure <100 mm Hg and a pulse >100 beats/min in a patient who was peripherally shut down and/or who required inotropes, an intra-aortic balloon pump, or cardiopulmonary support for the circulation (19) . Statistical analyses. Clinical outcomes were described with and without adjustment. Adjustment for in-hospital major adverse cardiovascular and cerebrovascular events (MACCE) was undertaken using the factors age, sex, procedure urgency, cardiogenic shock, left main stem PCI, graft PCI, history of a stroke, and the corresponding published coefficients from the North West Quality Improvement Project (NWQIP) risk model (21) . Cumulative unadjusted survival estimates were depicted using the Kaplan-Meier method, and differences across strata compared using the Mantle-Cox log-rank test. The associations with 30-day and 1-year mortality were quantified using fixed effects models, and estimates were expressed as adjusted odds ratios (aOR) with 95% confidence intervals (CI). Each model estimate was standardized using covariates selected after a published data review and in light of the results of directed acyclic graphs and statistical correlation. For all tests, a p value <5% was considered a cutoff point for statistical significance. All analyses were conducted using Stata IC version 12.0 (StataCorp LP, College Station, Texas). Sensitivity analyses. We undertook a series of sensitivity analyses to try to determine whether any of the following may have biased the results. We evaluated the impact of mixed effects models. Models were fitted with a hierarchy of patients clustered in each hospital (using random intercepts for hospitals, thus allowing for correlations between patient outcomes) and estimates compared with those from equivalent fixed effects models. Regression analyses were also considered by complete cases and after imputation for missing data. In total, 23 predictors of missing data were selected that were on the basis of clinical consensus and a published data review (3, 10, 13, 15, (22) (23) (24) (25) . The frequency of missing values ranged from 0.04% to 58.4% and were assumed to be missing at random. No data were missing for 1 of these variables, "clinical presentation," though this factor was still used in the imputation for the remaining 22 variables. Two other variables, "largest balloon/stent" and "longest stented segment," were not imputed because of colinearity. A predictor matrix was designed on the basis of clinical judgment as well as using thresholded p values of <5% as related. For continuous-continuous and continuous-categorical associations (continuous variables were modeled as the response), linear regression was used, whereas for categorical-categorical (including binary and ordinal variables), the chi-square test was used. For each of the 20 predictors with missing values, 20 datasets were imputed using the chained equation method (26, 27) . Continuous variables were imputed using predictive mean matching, and the categorical data imputed using polytomous regression. Finally, imputed datasets for each predictor were pooled together using Rubin's rule and followed by the intended regressions. For each of the STEMI, NSTEACS, and CSA groups, separate imputation datasets were created for 30-day and 1-year mortality. Imputation diagnostics were evaluated and did not give cause for concern. Ethics. NICOR, which hosts the BCIS (Ref: NIGB: ECC 1-06 (d)/2011) dataset, has support under section 251 of the NHS Act 2006. Under NHS research governance arrangements, formal ethical approval was not required for this study.
Results
A total of 10,410 patients received PCI to a LMS. Of these 5,065 (48.7%) had PCI to an UPLMS across 89 (78.1%) hospitals in England and Wales (Fig. 1) frequent in STEMI patients. A history of chronic renal failure was more frequent in patients with NSTEACS. In total, 323 (41.2%) STEMI and 222 (9.3%) NSTEACS patients presented with cardiogenic shock. Overall, the frequency of severe left ventricular systolic dysfunction (LVSD), defined as a left ventricular ejection fraction <30%, was 584 (17.9%), and was present in 148 (44.3%) cases of STEMI. The proportion of missing data for LVSD was 35.5%, reflecting the lack of a left ventricular angiogram or urgent echocardiogram in the acute setting at the time when the procedural part of the database was completed. Procedural characteristics. Femoral access was more frequent than radial access (STEMI: 68.5% vs. 30.1%, Across the strata of clinical presentation, crude 30-day and 1-year mortality rates were STEMI: 28.3% and 37.6%, NSTEACS: 8.9% and 19.5%, and CSA: 1.4% and 7.0%, respectively (Fig. 2) . After adjustment, acute cases remained at a significantly elevated risk of death (30-day mortality: STEMI aOR: 29.45, 95% CI: 19.37 to 44.80, NSTEACS aOR: 6.45, 95% CI: 4.27 to 9.76; 1-year mortality: STEMI aOR: 4.95, 95% CI: 4.07 to 6.02, NSTEACS aOR: 2.07, 95% CI: 1.76 to 2.43). Mortality rates in patients with STEMI who had cardiogenic shock were higher than in STEMI patients without shock (30 days: 52.0% vs. 11.7%, 1
year: 61.1% vs. 20.9%). Figure 3 shows that for STEMI and NSTEACS patients, the presence of cardiogenic shock was associated with significantly worse outcomes. In acute cases without cardiogenic shock, the radial approach, compared with the femoral approach, was associated with lower crude rates of mortality, but only at 30 days (STEMI 30 days: 14.8% vs. 6.2%, 1-year: 20.8% vs. 19.4%; NSTEACS 30 days: 7.4% vs. 5.7%, 1 year: 17.0% vs. 15.8%). Table 2 shows outcomes by clinical presentation. Predictors of 30-day mortality. Figure 4 shows the independent predictors of 30-day mortality by strata of clinical presentation. For STEMI and NSTEACS, predictors were age >80 years, pre-procedural cardiogenic shock, severe LVSD, pre-procedural ventilation, periprocedural coronary dissection, periprocedural shock, the use of IVUS, and the radial approach over femoral. There was no difference in risk of 30-day mortality by radial or femoral approach in patients with CSA. After adjustment, the mortality benefit of the radial approach was stronger in STEMI patients without cardiogenic shock, and not evident in NSTEACS patients without shock (STEMI aOR: 0.38, 95% CI: 0.17 to 0.86 and NSTEACS aOR: 0.75, 95% CI: 0.49 to 1.15). Other independent predictors of 30-day mortality were chronic renal failure and periprocedural AMI. By contrast, independent predictors for CSA were age >80 years and periprocedural coronary dissection. Predictors of 1-year mortality. Figure 5 shows the independent predictors of 1-year mortality by clinical presentation. For STEMI, predictors of 1-year mortality were age >80 years, pre-procedural cardiogenic shock, severe LVSD, pre-procedural ventilation, periprocedural coronary dissection, and periprocedural shock, For NSTEACS, the predictors were age >80 years, pre-procedural cardiogenic shock, previous MI, chronic renal failure, severe LVSD, preprocedural ventilation, periprocedural AMI, periprocedural shock, and the use of abciximab. For CSA, independent predictors were age >80 years and the use of abciximab. For STEMI, NSTEACS, and CSA, the radial approach was not a statistically significant predictor of 1-year mortality. In emergency patients without cardiogenic shock, the radial over the femoral approach was not significantly associated with lower risk of mortality at 1-year (STEMI aOR: 0.98, 95% CI: 0.60 to 1.61 and NSTEACS aOR: 1.11, 95% CI: 0.88 to 1.41). Sensitivity analyses. Although there was evidence for hospital (level 2) effects, the use of mixed effects models did not substantially affect the patient (level 1) estimates. Multiple imputation of missing data made only very small changes to point estimates generated from the models, though in general, imputation of missing data improved their precision.
Discussion
This is the first whole-country comparative outcomes study of UPLMS PCI according to clinical presentation. Our main finding in relation to our primary aim is that after consideration of case mix, patients who present with STEMI or NSTEACS in the context of UPLMS PCI have substantially higher risks of in-hospital MACCE as well as 30-day and 1-year mortality when compared with elective cases. Furthermore, more than 40% of patients who presented with STEMI had evidence of cardiogenic shock, and this was associated with a 9-fold increase in risk of mortality at 30 days and a 5-fold increase in risk of mortality at 1 year. Despite this, rates of 30-day all-cause mortality in patients with STEMI or NSTEACS were lower than the suggested benchmark of 55% (28) . These findings are of particular clinical relevance at a time when international guidelines recommend primary angioplasty in patients with STEMI and as complete revascularization as possible in those with established cardiogenic shock (29, 30) . The outcome data that we report in this observational study will be of value when considering the early and longer-term risk of outcomes after PCI for patients with an UPLMS stenosis in an elective setting.
In terms of adjuvant technologies, we have found that the use of an IABP was high in both STEMI and NSTEACS patients. In the light of recent trial data suggesting limited or no outcome benefit of IABP in the context of cardiogenic shock (31) , it will be interesting to see whether the use of this device decreases in these subgroups over time. By contrast, the use of an IVUS was lower than reported in other studies, but when used, was associated with improved outcomes, which is consistent with data previously published in the context of LMS PCI (32) (33) (34) . Notably, we found that overall, the radial approach to access was associated with better outcomes, but only at 30 days and only in STEMI and NSTEACS patients. We also found small differences in bleeding rates in radial versus femoral access. This finding may be an important observation because it adds weight to the recently reported finding that the radial access route is safer than femoral in STEMI patients and suggests that this benefit extends to NSTEACS patients in the real world (28, 35, 36) . Radial access may, however, reflect a less sick population and/or more skilled operators. Benefit of radial access is no longer evident at 1 year, possibly as a result of factors other than the index intervention that are associated with longer-term outcomes. For example, mortality at 1 year is more likely to be influenced by noncardiac factors than at 30 days (37) . Notably, the early mortality effect interacted significantly with the presence of cardiogenic shock (a much lower risk of 30-day mortality was evident in patients without cardiogenic shock).
We identified a number of additional factors associated with outcomes in patients treated by PCI to UPLMS. In keeping with results from other cohort studies, STEMI and NSTEACS patients were significantly associated with higher in-hospital MACCE and 30-day and 1-year mortality compared with stable presentations (10, 24) . For STEMI and NSTEACS patients, the significant predictors of 30-day mortality were cardiogenic shock, severe LVSD, pre-procedural ventilation, age >80 years, and peri-procedural shock: all factors that have previously been reported (10, 11, 13, 23, 38) . For CSA, the significant predictors of early mortality (age >80 years and periprocedural coronary dissection) were superseded by age >80 years, which independently predicted 1-year mortality. Similarly, chronic renal impairment and LVSD were not independent predictors of 1-year mortality in elective cases, in which group increasing age remained a strong predictor. Notably, the absolute level of 1-year mortality in the CSA cohort was higher than expected from previously reported data on UPLMS PCI. There is no formal explanation available for this finding, but it is of potential clinical relevance, and indeed bears closer scrutiny, when some interventionalists seek to extend the envelope for UPLMS PCI to include some patients who are suitable for CABG procedure.
Mortality rates summarized over the 6 years of our national study were lower than those reported by others. Parma et al. (10) described crude 30-day mortality rates for UPLMS PCI patients of 39.7%, and Brennan et al. (11) reported crude in-hospital mortality rates of 2.9% for CSA and 45.1% for emergent cases. A recent meta-analysis of UPLMS primary PCI outcomes in patients with AMI estimated the mean 30-day all-cause mortality rate to be 55% for patients with cardiogenic shock, which supports our observed rate of 52% for patients with STEMI (28) . Study strengths. The strengths of this study include the national data source that provides data in a large and unselected consecutive cohort of patients treated by PCI, the depth of detail of data, and the robust tracking of mortality by linkage of the NHS number.
Study limitations. Limitations include the fact that we were reliant on the accuracy of the data recorded from each operator and hospital. For the patients studied, we were not able to validate the procedural details or in-hospital MACCE, and these may suffer from information bias. In this paper, we presented a limited descriptive analysis on post-procedure bleeding, and we do know that bleeding is lower in the radial versus the femoral group; however, detailed modeling analysis is beyond the remit of this paper and is the subject of a separate study of the U.K. dataset that specifically addresses these interesting and complex issues. We cannot determine rates of repeat revascularization in follow-up because of the lack of such information in our dataset. We did not have sufficient data fields to calculate the EuroSCORE; nonetheless, we selected data to adjust for case mix using a previously published PCI outcomes model (21) . We found evidence for missing data and our underlying assumption that it was missing at random. This allowed the multiple imputation of missing data, which did not substantially change the model estimates generated. Finally, this study has disclosed many important associations, but cannot provide evidence for causation.
Conclusions
National data from the BCIS registry of PCI shows that more than one-half of patients treated with PCI to the UPLMS present acutely. For these cases, early and longerterm outcomes are significantly worse than for elective cases. Cardiogenic shock is common in STEMI patients and is associated with a 1-in-2 risk of early mortality. The radial approach to access was associated with improved early outcomes in acute cases, but was not supported by lower mortality in the longer term. Finally, 1-year mortality rates for CSA cases approached 1 in 10, which may have a bearing on the selection of elective cases for UPLMS PCI who are also suitable for CABG procedure.
